首页 | 本学科首页   官方微博 | 高级检索  
检索        


Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation
Authors:Rabea Asleh  Sarah Schettle  Alexandros Briasoulis  Jill M Killian  John M Stulak  Naveen L Pereira  Sudhir S Kushwaha  Simon Maltais  Shannon M Dunlay
Institution:1. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN;2. Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN;3. Department of Health Sciences Research, Mayo Clinic, Rochester, MN;4. Division of Cardiovascular Diseases, University of Iowa Hospitals and Clinics, Iowa City
Abstract:ObjectiveTo examine the frequency and outcomes of patients requiring renal replacement therapy (RRT) early after left ventricular assist device (LVAD) implantation.Patients and MethodsWe examined use of in-hospital RRT and outcomes in consecutive adults who underwent continuous-flow LVAD implantation from February 15, 2007, through August 8, 2017. Logistic regression was used to examine predictors of RRT. The associations of RRT with outcomes were examined using Cox proportional hazards regression.ResultsOf 354 patients who underwent LVAD implantation, 54 (15%) required in-hospital RRT. Patients receiving RRT had higher preoperative Charlson Comorbidity Index values (median, 5 vs 4; P=.03), Model for End-Stage Liver Disease scores (mean, 19.0 vs 14.5; P<.001), right atrial pressure (mean, 19.1 vs 13.4 mm Hg; P<.001), and estimated 24-hour urine protein levels (median, 357 vs 174 mg; P<.001) and lower preoperative estimated glomerular filtration rate (eGFR) (median, 43 vs 57 mL/min; P<.001) and measured GFR using 125I-iothalamate clearance (median, 33 vs 51 mL/min; P=.001) than those who did not require RRT. Approximately 40% of patients with eGFR less than 45 mL/min/1.73 m2 and 24-hour urine protein level greater than 400 mg required RRT vs 6% with eGFR greater than45 mL/min/1.73 m2 and without significant proteinuria. Lower preoperative eGFR, higher estimated 24-hour urine protein level, higher right atrial pressure, and longer cardiopulmonary bypass time were independent predictors of RRT after LVAD implantation. Of patients requiring in-hospital RRT, 18 (33%) had renal recovery, 18 (33%) required outpatient hemodialysis, and 18 (33%) died before hospital discharge. After median (Q1, Q3) follow-up of 24.3 (8.9, 49.6) months, RRT was associated with increased risk of death (adjusted hazard ratio HR], 2.86; 95% CI, 1.90-4.33; P<.001) and gastrointestinal bleeding (adjusted HR, 4.47; 95% CI, 2.57-7.75; P<.001).ConclusionIn-hospital RRT is associated with poor prognosis after LVAD. A detailed preoperative assessment of renal function before LVAD may be helpful in risk stratification and patient selection.
Keywords:BMI  body mass index  BTT  bridge to transplant  BUN  blood urea nitrogen  CPB  cardiopulmonary bypass  DT  destination therapy  ECMO  extracorporeal membrane oxygenation  eGFR  estimated glomerular filtration rate  ESRD  end-stage renal disease  HD  hemodialysis  HF  heart failure  HR  hazard ratio  IABP  intra-aortic balloon pump  ICD  implantable cardiac defibrillator  ICM  ischemic cardiomyopathy  INTERMACS  Interagency Registry for Mechanically Assisted Circulatory Support  LOS  length of stay  LVAD  left ventricular assist device  LVEDD  left ventricular end-diastolic diameter  LVEF  left ventricular ejection fraction  MAP  mean arterial pressure  MDRD  Modification of Diet in Renal Disease equation  MELD  Model for End-Stage Liver Disease  mPAP  mean pulmonary arterial pressure  NTBNP  NT pro-B–type natriuretic peptide  OR  odds ratio  PCWP  pulmonary capillary wedge pressure  PVR  pulmonary vascular resistance  RAP  right atrial pressure  RRT  renal replacement therapy  RV  right ventricular  WU  Wood units
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号